Aβ Chronic Exposure Promotes an Activation State of Microglia through Endocannabinoid Signalling Imbalance.
Alzheimer’s disease
endocannabinoid system
microglia
β-amyloid peptides
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
03 Apr 2023
03 Apr 2023
Historique:
received:
23
02
2023
revised:
12
03
2023
accepted:
31
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Dysfunctional phenotype of microglia, the primary brain immune cells, may aggravate Alzheimer's disease (AD) pathogenesis by releasing proinflammatory factors, such as nitric oxide (NO). The endocannabinoids
Identifiants
pubmed: 37047663
pii: ijms24076684
doi: 10.3390/ijms24076684
pmc: PMC10095368
pii:
doi:
Substances chimiques
Endocannabinoids
0
Amyloid beta-Peptides
0
Receptors, Cannabinoid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Ministry of University and Research
ID : 2017BTHJ4R_005
Organisme : Italian Ministry of University and Research
ID : 2017BTHJ4R_001
Références
Cell Rep. 2012 Jun 28;1(6):617-23
pubmed: 22813736
Nat Rev Drug Discov. 2010 May;9(5):387-98
pubmed: 20431570
Nat Rev Neurosci. 2015 Jun;16(6):358-72
pubmed: 25991443
Arch Neurol. 2012 Nov;69(11):1445-52
pubmed: 22925882
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3534-9
pubmed: 22331871
Br J Pharmacol. 2012 Apr;165(8):2635-51
pubmed: 21895628
Adv Drug Deliv Rev. 2020;159:133-169
pubmed: 32628989
Int J Mol Sci. 2022 May 12;23(10):
pubmed: 35628241
Cells. 2022 Apr 06;11(7):
pubmed: 35406803
Bio Protoc. 2016 Nov 5;6(21):
pubmed: 29104890
Pharmacol Res. 2016 Sep;111:721-730
pubmed: 27450295
J Neuroimmune Pharmacol. 2013 Mar;8(1):323-32
pubmed: 23299999
Glia. 2019 Feb;67(2):393-403
pubmed: 30485540
Immunology. 2015 Mar;144(3):352-364
pubmed: 25585882
J Neurosci. 2007 Mar 14;27(11):2883-9
pubmed: 17360910
Neurochem Int. 2012 Feb;60(3):286-91
pubmed: 22222721
Eur J Pharmacol. 2000 Oct 6;406(1):R5-7
pubmed: 11011050
Neuropharmacology. 2009;56 Suppl 1:244-53
pubmed: 18722389
Science. 2002 Jul 19;297(5580):353-6
pubmed: 12130773
Nat Rev Neurol. 2020 Jan;16(1):9-29
pubmed: 31831863
J Alzheimers Dis. 2015;45(4):1001-14
pubmed: 25663025
J Neurosci. 2003 Dec 3;23(35):11136-41
pubmed: 14657172
Chem Sci. 2022 Apr 1;13(19):5539-5545
pubmed: 35694350
J Neuroinflammation. 2014 Jun 03;11:98
pubmed: 24889886
Int J Mol Sci. 2020 Dec 22;22(1):
pubmed: 33375006
Brain. 2011 Apr;134(Pt 4):1041-60
pubmed: 21459826
Nat Neurosci. 2015 Jun;18(6):800-6
pubmed: 26007213
Trends Pharmacol Sci. 2014 Jun;35(6):284-92
pubmed: 24684963
J Neuroinflammation. 2005 Dec 12;2:29
pubmed: 16343349
Pharmacol Res. 2018 Apr;130:366-373
pubmed: 29454025
J Neuroinflammation. 2018 May 24;15(1):158
pubmed: 29793509
J Cell Biochem. 2001;81(4):715-23
pubmed: 11329626
Biomolecules. 2021 Mar 26;11(4):
pubmed: 33810505
J Neurosci. 2003 Feb 15;23(4):1398-405
pubmed: 12598628
Talanta. 2023 May 15;257:124392
pubmed: 36863295